Brick by brick: How AI-native biotechs are building investor confidence - BioXconomy

This matters because it highlights the increasing integration of AI in biotechnology, which can accelerate innovation and attract investment but also necessitates attention to potential risks.

Auto-scored: Article reports a positive trend in investor confidence with no direct AI risk events or significant mitigation measures.